Currently, Jean-Paul Kress is Chairman at ERYTech Pharma SA, CEO & Chairman-Management Board at MorphoSys AG and President & Director at Syntimmune, Inc.

He previously was President-International & Executive Vice President at Biogen, Inc., President & Chief Executive Officer at Sanofi Pasteur MSD SNC and Senior Vice President & Head-North America at Genzyme Corp.

Dr. Kress received an undergraduate degree and a graduate degree from École Normale Supérieure and a doctorate from Faculté De Médecine Necker Enfants Malades Université.